Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips.

Journal of Epidemiology
Tomohiro Shinozaki, Etsuji Suzuki

Abstract

Epidemiologists are increasingly encountering complex longitudinal data, in which exposures and their confounders vary during follow-up. When a prior exposure affects the confounders of the subsequent exposures, estimating the effects of the time-varying exposures requires special statistical techniques, possibly with structural (ie, counterfactual) models for targeted effects, even if all confounders are accurately measured. Among the methods used to estimate such effects, which can be cast as a marginal structural model in a straightforward way, one popular approach is inverse probability weighting. Despite the seemingly intuitive theory and easy-to-implement software, misunderstandings (or "pitfalls") remain. For example, one may mistakenly equate marginal structural models with inverse probability weighting, failing to distinguish a marginal structural model encoding the causal parameters of interest from a nuisance model for exposure probability, and thereby failing to separate the problems of variable selection and model specification for these distinct models. Assuming the causal parameters of interest are identified given the study design and measurements, we provide a step-by-step illustration of generalized computatio...Continue Reading

References

Mar 1, 1992·Epidemiology·J M Robins, S Greenland
Jul 1, 1991·Statistics in Medicine·S Greenland
Sep 1, 1986·International Journal of Epidemiology·S Greenland, J M Robins
Mar 1, 1986·American Journal of Epidemiology·J M Robins, S Greenland
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Nov 19, 2002·International Journal of Epidemiology·Sander Greenland, Babette Brumback
Oct 22, 2003·Epidemiology·Tosiya Sato, Yutaka Matsuyama
Mar 18, 2004·Journal of Epidemiology and Community Health·M A Hernán
Aug 17, 2004·Epidemiology·Miguel A HernánJames M Robins
Jan 13, 2006·Biometrics·Heejung Bang, James M Robins
Apr 14, 2006·Basic & Clinical Pharmacology & Toxicology·Miguel A HernánJames M Robins
Jun 23, 2006·Journal of Epidemiology and Community Health·Miguel A Hernán, James M Robins
Sep 19, 2007·American Journal of Epidemiology·James M RobinsAndrea Rotnitzky
Jun 3, 2008·Statistical Science : a Review Journal of the Institute of Mathematical Statistics·Anastasios A Tsiatis, Marie Davidian
Aug 7, 2008·American Journal of Epidemiology·Stephen R Cole, Miguel A Hernán
Mar 10, 2011·American Journal of Epidemiology·Michele Jonsson FunkMarie Davidian
Apr 18, 2012·Pharmacoepidemiology and Drug Safety·Wei Yang, Marshall M Joffe
Sep 14, 2012·Statistics in Medicine·Robert W PlattEnrique F Schisterman
Dec 5, 2012·Statistics in Medicine·R M DanielJ A C Sterne
Aug 2, 2013·The International Journal of Biostatistics·Liang Li, Tom Greene
Nov 28, 2013·Epidemiology·Nicolle M GattoSharon Schwartz
Feb 4, 2014·American Journal of Epidemiology·Sherri Rose, Mark van der Laan
May 16, 2014·Statistics in Medicine·S Vansteelandt, R M Daniel
Nov 21, 2014·Statistics in Medicine·Denis TalbotGeneviève Lefebvre
Jan 27, 2015·Statistical Science : a Review Journal of the Institute of Mathematical Statistics·Phillip J SchulteMarie Davidian
Oct 18, 2016·Epidemiology·Mohammad Ali MansourniaMiguel A Hernán
Oct 25, 2016·Annals of Epidemiology·Etsuji SuzukiEiji Yamamoto
Feb 1, 2017·Journal of Epidemiology·Etsuji SuzukiEiji Yamamoto
Mar 28, 2017·Epidemiology·Tomohiro ShinozakiYutaka Matsuyama
Sep 19, 2017·Annals of Statistics·Ilya Shpitser, Eric Tchetgen Tchetgen
Feb 1, 2018·Epidemiology·Alexander BreskinDaniel Westreich

❮ Previous
Next ❯

Software Mentioned

SAS
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.